| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2023 | Dec 2023 | Dec 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.64B | 14.00B | 13.13B | 13.13B | 13.13B | 13.13B |
| Gross Profit | 7.09B | 4.46B | 4.41B | 4.41B | 4.41B | 4.41B |
| EBITDA | 1.45B | 1.41B | 1.72B | 1.72B | 1.72B | 1.72B |
| Net Income | 997.00M | 959.00M | 1.21B | 1.21B | 1.21B | 1.21B |
Balance Sheet | ||||||
| Total Assets | 69.76B | 66.49B | 64.71B | 64.71B | 64.71B | 64.71B |
| Cash, Cash Equivalents and Short-Term Investments | 2.73B | 2.56B | 2.51B | 2.51B | 2.51B | 2.51B |
| Total Debt | 3.47B | 2.97B | 3.03B | 3.03B | 3.03B | 3.03B |
| Total Liabilities | 58.43B | 55.98B | 54.82B | 54.82B | 54.82B | 54.82B |
| Stockholders Equity | 11.32B | 10.51B | 9.89B | 9.89B | 9.89B | 9.89B |
Cash Flow | ||||||
| Free Cash Flow | 2.53B | 2.48B | 2.19B | 2.19B | 2.19B | 2.19B |
| Operating Cash Flow | 2.62B | 2.57B | 2.29B | 2.29B | 2.29B | 2.29B |
| Investing Cash Flow | -2.00B | -1.32B | -1.84B | -1.84B | -1.84B | -1.84B |
| Financing Cash Flow | -597.00M | -1.12B | -577.00M | -577.00M | -577.00M | -577.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $6.49B | 10.54 | 20.02% | 1.99% | 5.26% | 72.46% | |
76 Outperform | $11.86B | 14.92 | 16.91% | 6.86% | ― | -10.75% | |
74 Outperform | $5.71B | 16.28 | 19.49% | 4.21% | 3.72% | -16.23% | |
74 Outperform | $4.78B | 12.18 | 12.22% | 1.99% | 10.98% | 74.87% | |
69 Neutral | $12.00B | 12.12 | 9.03% | 8.57% | 5.41% | -23.52% | |
68 Neutral | $7.68B | 8.12 | 16.27% | 1.73% | 6.37% | 68.32% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
CNA Financial Corporation is a leading U.S. commercial property and casualty insurance company, offering a wide range of insurance products and services for businesses and professionals across the U.S., Canada, and Europe.
On November 3, 2025, CNA Financial announced that Dino E. Robusto will conclude his role as Executive Chairman of the Board and director on December 31, 2025, as per his Employment Agreement. Douglas M. Worman, currently President and CEO, will assume the role of Chairman of the Board starting January 1, 2026. Additionally, the Board of Directors has decided to reduce its size to ten members, effective the same date.
The most recent analyst rating on (CNA) stock is a Hold with a $51.00 price target. To see the full list of analyst forecasts on CNA Financial stock, see the CNA Stock Forecast page.
On August 12, 2025, CNA Financial successfully closed its offering of $500 million in 5.200% notes due in 2035. This financial move, executed under the company’s shelf registration statement, is expected to impact its financial strategy and stakeholder interests positively.
The most recent analyst rating on (CNA) stock is a Sell with a $48.00 price target. To see the full list of analyst forecasts on CNA Financial stock, see the CNA Stock Forecast page.
On August 5, 2025, CNA Financial entered into an underwriting agreement with Wells Fargo Securities, Citigroup Global Markets, and J.P. Morgan Securities for the offer and sale of $500 million in 5.200% notes due 2035. The sale is expected to close on August 12, 2025, and is part of CNA Financial’s strategy to leverage its effective shelf registration statement, potentially impacting its financial operations and market positioning.
The most recent analyst rating on (CNA) stock is a Sell with a $48.00 price target. To see the full list of analyst forecasts on CNA Financial stock, see the CNA Stock Forecast page.